What are Multi-agent chemotherapy combination drugs?

Multi-agent chemotherapy combination drugs are pharmacologic agents that share a common mechanism. 0 are currently marketed, with 3 more in clinical development.

Multi-agent chemotherapy combination

0 marketed 3 in Phase 3

This page covers all Multi-agent chemotherapy combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.

Phase 3 pipeline (3)

Course A1 + Vin · Children's Cancer Group, China · Oncology
Course A1 + Vin is a combination chemotherapy regimen that uses vincristine (Vin) alongside other agents in Course A1 to disrupt microtubule formation and induce apoptosis in cancer cells.
Course A3 + Vin · Children's Cancer Group, China · Oncology
Course A3 + Vin is a combination chemotherapy regimen combining doxorubicin, cyclophosphamide, and vincristine used to treat pediatric cancers.
Course B3 +Vin · Children's Cancer Group, China · Oncology
Course B3 + Vin is a combination chemotherapy regimen that uses vincristine (Vin) alongside other agents to disrupt cancer cell division and induce apoptosis in pediatric malignancies.